Menu
  • The inaugural holding of the US E-Cigarette Summit will take place in Washington DC, on Monday May 8, 2017
  • Registration for the US E-Cigarette Summit 2017 is now open

Dr Konstantinos Farsalinos M.D

Research Fellow
Onassis Cardiac Surgery Greece, Department of Pharmacology, University of Patras, Greece

Konstantinos E. Farsalinos, M.D., is a research fellow at the Onassis Cardiac Surgery Center in Athens, Greece, and at the Department of Pharmacy, University of Patras, Greece. He has been conducting laboratory and clinical research on e-cigarettes as a principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. He ran a worldwide online survey of almost 20,000 vapers (users of e-cigarettes) identifying patterns of use and experience with e-cigarettes among consumers, published in 2014. He has presented his research findings at major international scientific congresses and his research was used in preparing the regulatory framework on e-cigarettes by the European Union. As of April 2017, he has published more than 50 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction, and e-cigarettes. He was also the handling editor and author in a book titled “Analytical assessment of e-cigarettes”, published by Elsevier.

Competing Interest: For some of the studies, the institution has received funding from e-cigarette companies. None of the researchers received any compensation for participating to the studies.

Dr Konstantinos Farsalinos M.D will be speaking at:

Moderated Discussion and Q&A: Risk and Harm for Individual and Population Health

- 12:05 - 12:40

E-Cigarette Safety & Risk Profile – Methodology and clinical relevance

- 11:50 - 12:05

« Back to previous page